Clinical Implications of Complete Left-Sided Reverse Remodeling With Cardiac Resynchronization Therapy: A MADIT-CRT

Andrew Mathias1, Arthur J Moss1, Scott McNitt1

  • 1Heart Research Follow-Up Program, Cardiology Division, University of Rochester Medical Center, Rochester, New York.

Insights

Complete left-sided reverse remodeling in cardiac resynchronization therapy with a defibrillator (CRT-D) patients with left bundle branch block (LBBB) significantly lowers heart failure and death risk. This remodeling indicates a better long-term prognosis for CRT-D recipients.

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Management

Background:

  • The clinical significance of complete left-sided reverse remodeling, defined by reductions in left ventricular end-systolic volume (LVESV) and left atrial volume (LAV), following cardiac resynchronization therapy with a defibrillator (CRT-D) remains unclear.
  • Left-sided reverse remodeling encompasses changes in both the left ventricle and left atrium, crucial components of cardiac function.

Purpose of the Study:

  • To determine the rate of complete left-sided reverse remodeling in patients with left bundle branch block (LBBB) receiving CRT-D.
  • To evaluate the predictive value of complete left-sided reverse remodeling on the risk of heart failure (HF) and death in this patient cohort.
  • To compare outcomes among patients with complete, discordant, or lesser reverse remodeling.

Main Methods:

  • Analysis of 533 CRT-D patients with LBBB from the MADIT-CRT trial.
  • Categorization of patients into three groups: complete reverse remodeling (n=212), discordant reverse remodeling (n=115), and lesser reverse remodeling (n=206).
  • Primary endpoint: composite of HF or death; secondary endpoints: HF alone and death alone, assessed during long-term follow-up.

Main Results:

  • Patients with complete left-sided reverse remodeling demonstrated a significantly lower rate of HF or death compared to those with discordant or lesser reverse remodeling (p < 0.001).
  • Multivariate analysis confirmed a reduced risk of HF and death (HR: 0.66; 95% CI: 0.50-0.85; p = 0.002) in the complete reverse remodeling group.
  • Similar risk reductions were observed for HF alone and death alone endpoints.

Conclusions:

  • Complete left-sided reverse remodeling is achieved by a significant proportion of CRT-D patients with LBBB.
  • Complete left-sided reverse remodeling is a strong predictor of favorable long-term outcomes, significantly reducing the risk of heart failure and death.
  • Discordant reverse remodeling, observed in over 20% of patients, represents a distinct subgroup with potentially different prognostic implications.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
611
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
574
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
705
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
838
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
724
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
530